Single Port Laparoscopic Surgery for Complex Crohn's Disease Is Safe with a Lower Conversion Rate

Area of Science:

• Minimally Invasive Surgery
• Gastrointestinal Surgery
• Inflammatory Bowel Disease Management

Background:

• Single port laparoscopic surgery (SPLS) is gaining popularity.
• Its efficacy in complex Crohn's disease (CD), particularly in young patients requiring multiple surgeries, is not well-established.
• This study evaluates the initial experience with SPLS for complex CD.

Purpose of the Study:

• To assess the safety and feasibility of SPLS in patients with complex Crohn's disease.
• To analyze outcomes of primary versus redo SPLS for CD.
• To identify potential advantages of SPLS in this patient cohort.

Main Methods:

• Prospective data collection from January 2013 to December 2015.
• Inclusion of patients undergoing SPLS for complex CD, including ileocolic resections and small bowel stricturoplasties.
• Separate analysis of primary and redo operations.

Main Results:

• Forty-five patients (39 ileocolic resections, 6 stricturoplasties/resections) underwent SPLS.
• Median age was 41 years; median hospital stay was 8 days.
• No significant differences in operative time, blood loss, conversion rates, or complications between primary and redo surgeries; overall complication rate was 35.5% (mostly Clavien-Dindo I-II).

Conclusions:

• SPLS is a safe and viable option for complex Crohn's disease, including redo procedures.
• The technique may offer technical advantages in managing complex CD patients.
• Further research can explore long-term outcomes and specific benefits.